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Agonist-induced PIP, breakdown has been demonstrated in permeabilized vascular smooth muscle and shown to depend on a G protein. Segments 
of rat tail artery were permeabilized with ATP and EGTA after prelabeling with PHJinositol. Norepinephrine and GTPyS were both able to increase 
levels of IP, IP, and IP, in the segments. The effects of both norepinephrine and GTPyS on the segments was non-additive. Aluminum fluoride 
also increased inositol phosphates in intact segments and norepinephrine-stimulated increases in IP, IP, and IP, were insensitive to pertussis toxin. 
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1. INTRODUCTION 
Several hormones and neurotransmitters have been 
recently shown to stimulate the contraction of smooth 
muscle via the receptor-mediated breakdown of the 
lipid PIP2 [ 1,2]. This lipid breaks down to form IP3 and 
diacylglycerol [3]. The IP3 then binds to its receptor on 
the sarcoplasmic reticulum and induces the release of 
calcium stored within the SR into the cytosol [4,5]. The 
diacylglycerol released can stimulate the activity of pro- 
tein kinase C which can then phosphorylate a variety of 
cellular proteins [6]. The contraction of smooth muscle 
can be stimulated by the rapid rise in cytoplasmic 
calcium and perhaps by protein kinase C-stimulated 
protein phosphorylation as well [2,3]. 
In many different cellular systems G proteins have 
been shown to mediate the effects of agonists on the 
breakdown of PIP2 [7-91. The agonist binds to its 
receptor on the plasma membrane and stimulates the G 
protein to activate phospholipase C to hydrolyze the 
PIP2. In these studies either GTP or GTPyS were 
shown to stimulate the hydrolysis of PIP2 in either 
isolated membrane preparations or in permeable cell 
preparations [7-91. Aluminium fluoride (AlF., - ) was 
also shown to stimulate the breakdown of PIP2 in many 
of these cells [lO,ll]. In most of the cell types studied 
the agonist-mediated breakdown of PIP2 was not in- 
hibited by pertussis toxin [12,13], although agonist- 
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stimulated phospholipase C was very sensitive to per- 
tussis toxin in a variety of tissues [14,15]. 
The purpose of the current study was to investigate 
the role of G proteins in intact vascular smooth muscle. 
We have found for the first time that GTPyS and 
norepinephrine can stimulate the breakdown of PIP2 in 
permeabilized segments of rat tail artery. We have also 
found that AlFd- can stimulate PIP2 breakdown in tail 
artery and that the norepinephrine-stimulated produc- 
tion of inositol phosphates in this tissue is insensitive to 
pertussis toxin. This indicates that a pertussis toxin- 
insensitive G protein most likely mediates the effects of 
norepinephrine on PIP2 breakdown 
smooth muscle. 
in intact vascular 
2. MATERIALS AND METHODS 
2.1. Intact arteries 
Rats were sacrificed by excess COz exposure and the tail arteries 
quickly removed. The arteries were rinsed with bicarbonate-buffered 
PSS equilibrated with 95% Oz/S% COz at 37°C and pH 7.4. The 
solution had the following composition (in mM): NaCl 116.7, KC1 
4.5, CaClz 2.5, MgS04 1.2, NaHCOs 22.5, NaH2P04 1.2, NazS04 
2.4, D-glucose 5.6. The arteries were dissected free of extraneous con- 
nective tissue and then cut with a scalpel into segments of 5 mm. The 
segments were incubated at 37°C under an atmcsphere of 95% 
02/5% CO2 in a shaking water bath in 1 ml PSS for 60 min. The 
segments were then transferred to a tube containing 0.5 ml [‘HIin- 
ositol(10 pCi) in PSS and the incubation continued for 150 min. The 
segments were then treated with LiCl (10 mM) for 30 min and then 
treated with various agonists for 20 min before being quick-frozen in 
liquid NZ and thawed in trichloracetic acid (lo%, 4°C). The solutions 
were then extracted 4 times with ethyl ether to remove the 
trichloracetate. The solutions containing inositol phosphates were 
then applied to small (0.5 ml) columns of Dowex 1 x 8-400 (200-400 
mesh) resin and eluted sequentially with 10 ml each of water, 0.2 M 
ammonium formate/O.l M formic acid, 0.4 M ammonium for- 
mate/O. 1 M formic acid, and 0.8 M ammonium formate/O. 1 M for- 
mic acid. Each 10 ml step applied to each column was collected off the 
column as a single 10 ml fraction. Then 2.5 ml aliquots of each frac- 
tion were added to scintillation fluid (16 ml of Ecolume) and the 
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radioactivity in the samples determined with a Beckman LS3801 scin- 
tillation counter. 
2.2. Permeable arteries 
In order to measure the metabolism of inositol lipids in permeable 
rat tail arteries, the tail arteries were prepared, divided into segments, 
and pretreated with [‘Hlinositol for 3 h as described for intact 
arteries. The arteries were then treated for 30 min at 20°C with 
permeabilization solution 1, using a modification of the procedure 
first applied to smooth muscle by Morgan and Morgan [ 161. The com- 
position of permeabilization solution 1 was as follows (in mM): 
EGTA 10, ATP 5, KC1 120, MgCl2 2, TES buffer 20, [‘HJinositol 
0.025, 20 &i/ml, CTP 0.1, pH 7.0. The arteries were then incubated 
for 30 min at 20°C with permeabilization solution 2. The composition 
of permeabilization solution 2 was as follows (in mM): EGTA 1, ATP 
5, KC1 120, MgCla 6, TES buffer 20, inositolO.025, 20yCi/ml, CTP 
0.1, CaClz 0.122, pH 7.0. The segments were then incubated at 37°C 
in permeabilization solution 2 together with LiCl (10 mM) and 
agonists. The incubations were terminated by the addition of 2 ml 
trichloracetate (lo%, 4°C). The trichloracetate was removed with 
ether and then the acqueous extracts were applied to Dowex columns 
as described above. 
2.3. Materials 
Sprague-Dawley rats (male, 2-4 months old) were obtained from 
Taconic (Germantown, NY). Myo-[2-‘Hlinositol was obtained from 
American Radiolabeled Chemicals (St. Louis, MO). Norepinephrine, 
Dowex 1 x 8-400, pertussis toxin, and GTPyS were obtained from 
Sigma (St. Louis, MO). 
3. RESULTS 
In preliminary experiments rat tail artery segments 
were prelabeled with [3H]inositol, and then treated by 
the procedure of Morgan and Morgan [16] in order to 
first render them permeable to small molecules and then 
to subsequently reseal the membranes before treatment 
with norepinephrine. When these ‘resealed’ segments 
were then frozen and the inositol phosphates extracted 
and separated, it was found that the segments no longer 
contained any inositol phosphates. However, when we 
extracted the bathing medium outside the segments, a 
substantial amount of inositol phosphates were 
recovered. This indicated that the ‘resealing’ procedure, 
in our hands, did not succeed, but that norepinephrine 
could still stimulate the release of inositol phosphates 
Table II 
Effect of norepinephrine and aluminum fluoride on inositol 
phosphates in rat tail artery 
cpm mean + S.D. (n =4) 
IP IP2 
Control 3711 f 240 778 t 69 
Norepinephrine 16576 _+ 2349* 6326 t 1047* 
Aluminum fluoride 5223 * 771** 1431 + 86* 
Rat tail artery segments were treated with [‘Hlinositol as described in 
section 2 and then treated with either norepinephrine (lo- ’ M), AlCI, 
(10 PM) plus KF (5 mM) or nothing for 20 min and then frozen in li- 
quid N2 and thawed in trichloracetic acid (lo%, 0°C). The inositol 
phosphates were separated by Dowex column chromatography as 
described in section 2. 
Significantly different from control: *P<O.OOS, **P<O.O25 
from the permeable cells and these compounds could be 
measured in the medium outside the cells. 
Norepinephrine was shown to significantly stimulate 
the production of IP, IPz and IP3 in permeable 
segments of rat tail artery (Table I). GTPyS (a non- 
hydrolyzable analogue of GTP) was also shown to 
significantly stimulate the production of the inositol 
phosphates in permeable segments of the tail artery. 
When segments of tail artery were exposed to both 
norepinephrine and GTPyS simultaneously, the pro- 
duction of inositol phosphates was increased in a non- 
additive process (Table I). This indicated that a G pro- 
tein in the tail artery perhaps was capable of mediating 
the effects of norepinephrine on the phospholipase C 
that hydrolyzed PIP2 in the tissue to form IPs and 
diacylglycerol. 
Since other investigators have used a mixture of 
aluminum and fluoride ions to stimulate certain G pro- 
teins, we added AlF4 - to tail artery segments that had 
been prelabeled with [3H]inositol and found that the 
mixture was capable of sifnificantly stimulating the 
release of IP and IP2 from the labeled lipid in the tissue 
(Table II). 
Table I 
Effect of norepinephrine and GTPrS on inositol phosphates in permeable tail artery 
cpm means + S.D. (n=9) 
IP IP2 IP3 
Control 1211 f 248 257 + 41 38 * 3 
Norepinephrine (10 - ’ M) 7504 f 2782* 3088 + 1634* 92 * 30* 
GTPrS (1O-4 M) 2762 + 607* 569 + 144* 44 + 5** 
GTPyS + norepinephrine 4930 k 2385* 1601 + 756* 55 f 12* 
Segments of rat tail artery were treated with [‘Hlinositol and permeabilized as 
described in section 2 before being treated with LiCl (10 mm) and the compounds 
listed above for 20 min at 37°C. The tubes were then extracted with 2 ml 
trichloracetate and the inositol phosphates in the samples separated by Dowex col- 
umn chromatography as described in section 2. 
Significantly different from control: *PC 0.005, **PC 0.01. 
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Table III 
Effect of pertussis toxin on norepinephrine stimulation of inositol phosphate release 
in tail artery 
cpm m f S.D. (n=4) 
IP lP2 IP3 
Control 244 * 50 293 + 38 316 f 68 
Norepinephrine (10d5 M) 11390 I 2484 7171 -+ 1187 753 f 151 
Pertussis toxin (5 @g/ml) 365 f 145 418 k 125 432 f 50 
Pert&s toxin + 
norepinephrine 7850 -e 1836 5263 + 1271 864 f 200 
Segments of rat tail artery were preincubated with medium and with j3H]inositol- 
containing medium as described in section 2. After 2 h in [3H]inositoI they were in- 
cubated for 1 h at 37°C with [‘Hlinositol, LiCl(10 mM) either with or without per- 
tussis toxin (5 &ml) and then treated with or without norepinephrine (lo-’ M) for 
20 min at 3FC before being frozen and extracted as described in section 2. 
Pertussis toxin has been shown to inhibit the activity 
of certain G proteins in certain tissues, and so we added 
pertussis toxin to norepinephrine-stimulated segments 
of rat tail artery. Pertussis toxin did not significantly 
alter either the norepinephrine-stimulated levels of IP, 
IPz, or IPs in the tissue or the background levels of the 
inositol phosphates observed in the segments of tail 
artery (Table III). It appeared that the G protein present 
in the smooth muscle of intact rat tail artery was insen- 
sitive to pertussis toxin. 
4. DISCUSSION 
Recently, Nishimura et al. [17], together with 
Kobayashi et al. [I] have shown that smooth muscle 
could be permeabilized with a-toxin and the resulting 
preparations would contract in response to agonists 
such as norepinephrine or carbachol only in the 
presence of GTP. This idicated that one or more G pro- 
teins most likely mediated the effects of these agonists 
on the contractions of the smooth muscle. Other in- 
vestigators have demonstrated that either GTP or the 
non-hydrolyzable GTP analogue, GTP-& could 
stimulate the breakdown of PIP2 to form IP, in either 
cultured smooth muscle cell membranes [18] or in the 
homogenate of canine coronary arteries 1191. Similar 
studies have demonstrated that GTPyS could stimulate 
the breakdown of PIP2 in either permeable cells or 
membranes from a variety of tissues [7,8]. These ex- 
periments indicate that one or more G proteins most 
likely mediate the action of a contractile agonist on 
phospholipase C directly. Further evidence in support 
of this theory comes from the work of those who have 
shown that the ion AlF4 - can stimulate the breakdown 
of PIP2 to form IF’3 in Cells from ileum [2O] and 
myometrium [12], as well as from other tissues [lo]. 
Some of these studies have found that agonist-sensitive 
PIP2 breakdown is inhibited by pertussis toxin [14,15] 
and pertussis toxin is believed to exert its effects on 
metabolism via the inactivation of G proteins. Other 
studies have found that agonist-sensitive PIP2 
breakdown is insensitive to pertussis toxin in several 
tissues [12,13]. Since PIP2 breakdown in nearly all of 
the latter tissues is stimulated by either GTP, GTPyS, 
or by AlF4 - it appears likely that a pertussis toxin- 
insensitive G protein is required to mediate the effects 
fo agonists on phospholipase C in such tissues. 
In none of the above studies has anyone investigated 
the sensitivity of phospholipase C to GTP or GTP 
analogues in intact vascular smooth muscle, nor have 
they examined the sensitivity of this enzyme system to 
pertussis toxin in intact vascular smooth muscle. We 
have found that GTPyS can stimulate the breakdown 
of PIP;! in permeabilized cells of rat tail artery, as does 
norepinephrine itself. The two agonists together do not 
exert additive effects on the production of inositol 
phosphates in this tissue. This indicates that GTPyS 
most likely interacts with the same G protein that 
norepinephrine must interact with in order to stimulate 
PIP2 breakdown in the cells. We have also shown that 
inositol phosphate levels increase in rat tail artery in 
response to the addition of F- and Al3 + salts, 
presumably resulting from the formation of AlF4 - that 
many investigators have shown to stimulate the activity 
of G proteins. Since we have not found that agonist- 
mediated PIP2 metabolism in rat tail artery is sensitive 
to pertussis toxin, one can conclude that the G protein 
involved is insensitive to this toxin. Of course, the in- 
cubation period employed in our experiments was short 
(60 min) and others have used much longer incubation 
periods (30 h [21]). However, we used a much higher 
concentration of pertussis toxin (5 pg/ml) than other in- 
vestigators (10 ng/ml [ 15]), which might be expected to 
make up for the shortness of our incubation period. 
Our tissue would not survive 30-h incubation periods. 
In conclusion, we have demonstrated that norepine- 
phrine-stimulated PIP2 breakdown in intact vascular 
smooth muscle requires the assistance of a pertussis 
toxin-insensitive G protein, and that this G protein no 
doubt plays a role in the agonist-stimulated contrac- 
tions of this tissue. 
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